Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+ Industry Domains
Report
Press Release
Blogs
Industry Statistics
Add 2 More Reports For 20% off

Report Overview

Hepatitis A is an acute liver infection caused by the hepatitis A virus (HAV), primarily transmitted through contaminated food and water. As per Ammara Abdul Majeed et al. (2025), approximately 14 million cases occur globally. This viral hepatitis burden highlights the importance of prevention. According to hepatitis A epidemiology forecast by Expert Market Research, disease trends remain important for market assessment.

2025

Base Year

2019-2025

Historical Period

2026-2035

Forecast Period

Hepatitis A – Number of Cases by Year

Read more about this report - Request a Free Sample

Hepatitis A Epidemiology Forecast Report Coverage

Expert Market Research's “Hepatitis A Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of hepatitis A. It projects the future incidence and prevalence rates of hepatitis A cases across various populations. The study covers age, gender, and type as major determinants of the hepatitis A population. The report highlights patterns in the prevalence of hepatitis A over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of hepatitis A in the 8 major markets.

Regions Covered

  • United States
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Japan
  • India

Hepatitis A Understanding: Disease Overview

Hepatitis A is a contagious liver infection caused by the hepatitis A virus (HAV), which is primarily transmitted through the ingestion of contaminated food or water or through close contact with an infected person. The infection causes liver inflammation and may result in fatigue, nausea, abdominal discomfort, dark urine, and jaundice. Unlike hepatitis B and C, hepatitis A does not cause chronic liver infection. Disease severity ranges from mild, self-limiting illness to severe, occasionally life-threatening complications, particularly among older adults and individuals with preexisting liver disease. Fecal-oral transmission is the principal route of infection.

Key Report Insights

Parameter

Insight

Largest Patient Pool

India

Fastest Growing Country

India

High-Risk Population

Children in endemic settings, unvaccinated individuals, international travelers, and people with chronic liver disease

Key Diagnostic Method

Detection of immunoglobulin M antibodies against hepatitis A virus (anti-HAV IgM) in blood

Major Risk Factor

Consumption of food or water contaminated with the hepatitis A virus, particularly where sanitation and hygiene are inadequate

Major gap in the market

Unequal access to vaccination, limited awareness, and gaps in timely diagnosis and outbreak surveillance

Hepatitis A Epidemiology Perspective

The hepatitis A epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the hepatitis A epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for hepatitis A and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

Epidemiology Segment

Key Insights

Diagnosed Prevalent Cases of the Disease

According to Ammara Abdul Majeed et al. (2025), hepatitis A affects tens of millions of people globally, with approximately 14 million cases and 28,000 deaths annually, highlighting its continuing public health burden across different settings.

Gender-Specific Cases of the Disease

According to Hyunjin Son et al. (2024), hepatitis A incidence has historically been higher among men, although gender patterns have changed, highlights the importance of monitoring sex-specific trends in disease surveillance.

Age-Specific Cases of the Disease

According to the Centers for Disease Control and Prevention, the highest reported hepatitis A rate in the United States in 2021 occurred among adults aged 30-39 years, at 3.9 cases per 100,000 population.

Ethnicity-Wise Cases of the Disease

According to Centers for Disease Control and Prevention, the hepatitis A case rate among Hispanic individuals in the United States in 2023 was 2.0 times the rate among non-Hispanic White individuals, indicating differences in the reported disease burden across ethnic populations.

Mortality and Survival Analysis of the Disease

According to Ammara Abdul Majeed et al. (2025), hepatitis A caused approximately 28,000 deaths annually worldwide, compared with 7,134 deaths reported in 2016. These estimates highlight the continuing contribution of hepatitis A to global mortality.

Type-Specific Disease Burden and Epidemiology Analysis

Disease Type

Prevalence and Epidemiology

Genotype I

One of the major human-infecting genotypes of hepatitis A virus, contributing to human infections across different regions. Its distribution is influenced by sanitation, food and water hygiene, and population immunity.

Genotype II

A human-infecting genotype associated with hepatitis A cases. Its contribution to the overall disease burden varies by geographic region, and molecular surveillance helps assess its distribution.

Genotype III

A major human-infecting genotype that contributes to the global burden of hepatitis A. Its prevalence varies geographically, with molecular surveillance supporting the identification of circulating strains.

Genotypes IV, V, and VI

These genotypes primarily infect nonhuman primates and do not account for the major share of human hepatitis A cases, which are primarily associated with genotypes I, II, and III.

Hepatitis A – Number of Cases by Country

Read more about this report - Request a Free Sample

Country-wise Hepatitis A Epidemiology

The hepatitis A epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Country

Key Insights

United States

According to Centers for Disease Control and Prevention, the reported hepatitis A rate in the United States was 1.7 cases per 100,000 population in 2021, representing a 43% decrease from 2020. As per Centers for Disease Control and Prevention, 1,648 new cases and 85 hepatitis A-related deaths were reported in 2023, while estimated infections reached 3,300 after adjustments for underascertainment and underreporting. The case count declined by 28% between 2022 and 2023. Adults aged 30-39 years had the highest reported case rate in 2023.

Germany

Cross-border transmission, foodborne exposure, sanitation, population immunity, and outbreak surveillance can influence the occurrence and detection of hepatitis A cases in Germany.

France

According to Kazuteru Murakoshi et al. (2025), the average annual incidence of hepatitis A in France was 1.79 in the study's reported incidence measure during 2007-2021. Outbreaks were recorded in 2009 and 2017. Hepatitis A cases increased by 489% in 2017, potentially in association with the wider outbreak affecting men who have sex with men. Following the COVID-19 pandemic, reported cases decreased significantly. These findings highlight temporal fluctuations in disease occurrence and the importance of ongoing surveillance.

Italy

According to Angela Domínguez et al. (2025), Italy has an incidence of hepatitis A below the threshold of 5 cases per 100,000 inhabitants, similar to Spain and Portugal. This places Italy among settings with low reported incidence in the comparative information provided. Continued monitoring of reported cases and changes in exposure patterns remains relevant for understanding the national epidemiological profile. The supplied information does not provide a specific Italian annual case count, age distribution, or mortality estimate.

Spain

According to Angela Domínguez et al. (2025), Spain recorded a cumulative hepatitis A hospitalization incidence of 8.84 per million population over a 22-year period. The corresponding rates were 12.54 per million among men and 5.26 per million among women. The study also reported a hepatitis A incidence rate below 5 per 100,000 inhabitants. According to the same authors, seroprevalence among individuals aged 30-39 years was 22.94% in 2017-2018. Hospitalization outcomes varied by age and underlying health conditions.

United Kingdom

Hepatitis A epidemiology in the United Kingdom can be assessed through reported cases, age-specific incidence, outbreak surveillance, and population immunity. Monitoring changes in case distribution can help identify shifts in transmission patterns and inform public health responses. Comparisons with other countries should consider differences in surveillance methods, reporting practices, and the periods covered by available estimates. The supplied information does not include a United Kingdom-specific incidence rate, prevalence estimate, annual case count, or mortality figure.

Japan

According to Kazuteru Murakoshi et al. (2025), Japan's average hepatitis A incidence was 0.21 in the study's reported incidence measure during 2007-2021. Outbreaks were recorded in 2010, 2014, and 2018, and cases increased by 324% in 2018. In 2014, 80.5% of cases were associated with contaminated seafood or water. According to European Medical Group Ltd., hepatitis A cases had decreased by 89.5% by 2021, while infections among individuals aged 70 years and older remained stable.

India

According to Beacon (2025), Kerala reported 31,536 confirmed and probable hepatitis A cases and 82 deaths as of December 30, 2025. The state recorded 28,412 cases and 96 deaths in 2024, compared with 4,581 cases and 15 deaths in 2023. The reported age distribution shifted toward adolescents and adults aged 20-40 years. These figures indicate sustained transmission in Kerala during 2024-2025. The supplied figures relate specifically to Kerala and should not be interpreted as national estimates for India.

Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape

Hepatitis A epidemiology across the United States, Germany, France, Italy, Spain, the United Kingdom, Japan, and India varies with sanitation, vaccination coverage, population immunity, and exposure patterns. India presents opportunities to strengthen preventive vaccination strategies, improve access to safe water, and enhance outbreak surveillance. In the other countries, targeted vaccination for susceptible high-risk groups, improved awareness among international travelers, and timely identification of outbreaks remain important priorities. Strengthening laboratory diagnosis, public health reporting, and access to preventive interventions can help address regional gaps and reduce the disease burden.

Hepatitis A: Treatment Overview

There is no specific antiviral treatment for hepatitis A. Management primarily involves supportive care, including adequate rest, hydration, balanced nutrition, and symptom management. Patients should avoid alcohol and consult healthcare professionals before using medications that may affect liver function. Severe cases involving acute liver failure may require hospitalization and specialized medical care. Hepatitis A vaccination is an effective preventive measure, while post-exposure prophylaxis with a vaccine or immune globulin may be recommended for eligible individuals, depending on age, health status, and exposure timing. Supportive therapy remains the primary approach for uncomplicated infections.

Key Questions Answered

  • What is the current and projected burden of hepatitis A across the 8 major markets?
  • Which countries across the 8 major markets account for the highest hepatitis A patient populations and fastest growth rates?
  • What is the diagnosed versus undiagnosed patient population of hepatitis A across key countries in the 8 major markets?
  • Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of hepatitis A across the 8 major markets?
  • What are the major drivers contributing to the increasing burden of hepatitis A across the 8 major markets?
  • How do major comorbidities and risk factors influence hepatitis A epidemiology trends across the 8 major markets?
  • What are the regional trends in advanced disease progression, treatment uptake, and patient management of hepatitis A across the 8 major markets?
  • Which patient segments represent the highest unmet clinical need in the Hepatitis A landscape across the 8 major markets?
  • Which therapeutic areas linked to hepatitis A are expected to witness the strongest growth opportunities across the 8 major markets?
  • How is the hepatitis A epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
  • Which countries across the 8 major markets offer the most attractive market opportunities based on hepatitis A epidemiology and healthcare infrastructure?
  • Which epidemiological trends are expected to influence future drug development and market access strategies for hepatitis A across the 8 major markets?

Scope of the Hepatitis A Epidemiology Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of hepatitis A based on several factors.
  • Hepatitis A Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The hepatitis A report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Alcoholic Hepatitis Treatment Market

Hepatitis D Epidemiology Forecast

Hepatitis B Infection Treatment Market

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Report Summary

Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.

Key Highlights of the Report

Please note that the figures mentioned in the description serve as estimates and may vary from the actual figures presented in the final report.

Report Features

Details

Base Year

2025

Historical Period

2019-2025

Forecast Period

2026-2035

Epidemiology Statistics Provided

  • Diagnosed Prevalent Cases
  • Type-Specific Cases
  • Gender-Specific Cases
  • Age-Specific Cases

Segmentation Provided

  • Epidemiology by Age Group
  • Epidemiology by Gender
  • Epidemiology by Type of Disease
  • Epidemiology by Region

Geographies Covered

  • United States
  • Germany
  • Italy
  • France
  • Spain
  • United Kingdom
  • Japan
  • India

Datasheet

10 % Off

USD

2,699

2,429

Single User License

10 % Off

USD

4,299

3,869

Five User License

15 % Off

USD

5,799

4,949

Corporate License

15 % Off

USD

6,999

5,949

Datasheet

One User

USD 2,699

USD 2,429

tax inclusive*

  • Selected Segments
  • Printing Restrictions
  • Excel Spreadsheet Delivered via Email
  • Full Report
  • Periodic Updates
  • Post Sales Analysts Support
  • Unlimited Prints

Single User License

One User

USD 4,299

USD 3,869

tax inclusive*

  • All Segments
  • Printing Restrictions
  • PDF Delivered via Email
  • Custom Report Layout
  • Post Sales Analysts Support
  • Periodic Updates
  • Unlimited Prints

Five User License

Five User

USD 5,799

USD 4,949

tax inclusive*

  • All Segments
  • Five Prints Available
  • PDF Delivered via Email
  • Limited Free Customization
  • Post Sales Analyst Support
  • Custom Report Layout
  • Periodic Updates
  • Unlimited Prints

Corporate License

Unlimited Users

USD 6,999

USD 5,949

tax inclusive*

  • All Segments
  • Unlimited Prints Available
  • PDF & Excel Delivery via Email
  • Limited Free Customization
  • Post Sales Analysts Support
  • Discount On Next Update
  • Custom Report Layout

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Bundle Type

Flash Bundle

20% OFF Number of Reports: 3

Small Business Bundle

25% OFF Number of Reports: 5

Growth Bundle

30% OFF Number of Reports: 8

Enterprise Bundle

35% OFF Number of Reports: 10
Overview
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 80 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards
  • Life Time Access
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 100 Hours
  • Complimentary Free 1 Month Subscription to Trade Data Base
  • Complimentary One Month Subscription to Price Database (Chemicals only)
  • Complimentary PPT Version of the Report
  • Complimentary License Upgrade
  • Complimentary Power BI Dashboards

*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*

Flash Bundle

Number of Reports: 3

20%

tax inclusive*

  • 3 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade
  • Free Analyst Hours

Small Business Bundle

Number of Reports: 5

25%

tax inclusive*

  • 5 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • Complimentary Excel Data Set
  • PPT Version of the Report
  • Power BI Dashboards
  • License Upgrade

Growth Bundle

Number of Reports: 8

30%

tax inclusive*

  • 8 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Free Analyst Hours - 80 Hours
  • Power BI Dashboards

Enterprise Bundle

Number of Reports: 10

35%

tax inclusive*

  • 10 Reports Included
  • Life Time Acess
  • Analyst Support Related to Report
  • PDF Version of the Report
  • Complimentary Excel Data Set
  • Free Analyst Hours - 50 Hours
  • Free 1 Month Subscription to Trade Data Base
  • 1 Month Subscription to Price Database (Chemicals only)
  • License Upgrade
  • Power BI Dashboards
  • Free Analyst Hours - 100 Hours

How To Order

This is a collaborative report by Vishakha Agrawal reflecting perspectives and research-driven insights from Expert Market Research.

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

License Type

Select License Type

Choose the right license for your needs and access rights.

shopping cart

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Bookmark Icon

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us